French Registry: Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy

This study aims to create a registry of patients with hypertrophic cardiomyopathy, a condition characterized by excessive thickening of the heart muscle. This disease can sometimes lead to serious complications. Currently, the prognosis of these patients is mainly determined by clinical and echocardiographic parameters. Detection of myocardial fibrosis using cardiac MRI enables better risk stratification for these patients.

NCT Number	NCT07428031
Lead Sponsor	Assistance Publique - Hôpitaux de Paris
Conditions	Cardiomyopathy, Hypertrophic Cardiomyopathies
Enrollment	5,000 participants
Start Date	2026-03-01
Primary Completion	2031-03-01 (estimated)
Study Completion	2036-03-01 (estimated)
Updated on ClinicalTrials.gov	2026-02-23